What question did this study set out to answer?

The research aims to characterize the anti-breast cancer activity of red ginseng polysaccharide RGP-45, involving its extraction and purification.

February 28, 2026Results in ChemistryOpen Access

Characterization and study on the anti-breast cancer activity of polysaccharides from red ginseng

View Full Paper

Ask AI

Bookmark

Authors

Research characterizes red ginseng polysaccharide RGP-45 and its anti-breast cancer effects, highlighting its therapeutic potential.

The research aims to characterize the anti-breast cancer activity of red ginseng polysaccharide RGP-45, involving its extraction and purification.
Extracted polysaccharides from red ginseng were purified and named RGP-45.
Characterization included determining yield, molecular weight, and sugar composition.
In vitro tests assessed effects on 4T1 cell proliferation and apoptosis.
In vivo tests evaluated RGP-45's impact on tumor growth in breast cancer mice models.
RGP-45 yielded 12.59% with a relative molecular weight of 27.8 kDa and total sugar content of 91.57%.
RGP-45 significantly inhibited 4T1 cell proliferation and promoted apoptosis.
In vivo, RGP-45 treatment inhibited tumor growth in mice.
RGP-45 treatment alleviated liver and lung damage in mice bearing tumors.

Li et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

February 28, 2026Results in ChemistryOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Research characterizes red ginseng polysaccharide RGP-45 and its anti-breast cancer effects, highlighting its therapeutic potential.

The research aims to characterize the anti-breast cancer activity of red ginseng polysaccharide RGP-45, involving its extraction and purification.
Extracted polysaccharides from red ginseng were purified and named RGP-45.
Characterization included determining yield, molecular weight, and sugar composition.
In vitro tests assessed effects on 4T1 cell proliferation and apoptosis.
In vivo tests evaluated RGP-45's impact on tumor growth in breast cancer mice models.
RGP-45 yielded 12.59% with a relative molecular weight of 27.8 kDa and total sugar content of 91.57%.
RGP-45 significantly inhibited 4T1 cell proliferation and promoted apoptosis.
In vivo, RGP-45 treatment inhibited tumor growth in mice.
RGP-45 treatment alleviated liver and lung damage in mice bearing tumors.

Li et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark